ZERIA PHARMCEUTICAL CO., LTD. Logo

ZERIA PHARMCEUTICAL CO., LTD.

Develops and distributes prescription & consumer healthcare products in Europe and Asia.

4559 | T

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
Japan
Address:
中央区日本橋小舟町10番11号
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Zeria Pharmaceutical Co., Ltd. is a comprehensive healthcare company engaged in the research, development, manufacturing, and distribution of pharmaceutical products. The company operates through two primary business segments: Ethical Pharmaceuticals (prescription drugs) and Consumer Healthcare (over-the-counter products). Its consumer product portfolio includes nutritional health drugs, remedies for gastrointestinal diseases, cold remedies, and ophthalmic solutions. Zeria actively expands its R&D pipeline by in-licensing and developing drugs with established sales records in overseas markets, distributing its products internationally across Europe and Asia.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-03 07:19
Post-Annual General Meeting Information
臨時報告書
Japanese 23.2 KB
2025-06-26 03:01
Regulatory News Service
内部統制報告書-第71期(2024/04/01-2025/03/31)
Japanese 24.9 KB
2025-06-26 03:00
Regulatory News Service
確認書
Japanese 8.4 KB
2025-06-26 03:00
Annual Report
有価証券報告書-第71期(2024/04/01-2025/03/31)
Japanese 1.5 MB
2024-11-08 02:01
Report Publication Announcement
確認書
Japanese 8.3 KB
2024-11-08 02:00
Interim Report
半期報告書-第71期(2024/04/01-2025/03/31)
Japanese 204.2 KB
2024-07-03 03:44
Post-Annual General Meeting Information
臨時報告書
Japanese 23.8 KB
2024-06-27 07:11
Regulatory News Service
確認書
Japanese 8.4 KB
2024-06-27 07:09
Regulatory News Service
内部統制報告書-第70期(2023/04/01-2024/03/31)
Japanese 23.8 KB
2024-06-27 07:07
Annual Report
有価証券報告書-第70期(2023/04/01-2024/03/31)
Japanese 1.2 MB
2024-02-05 06:04
Quarterly Report
四半期報告書-第70期第3四半期(2023/10/01-2023/12/31)
Japanese 168.4 KB
2024-02-05 06:04
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-11-06 07:10
Report Publication Announcement
確認書
Japanese 8.3 KB
2023-11-06 07:09
Interim Report
四半期報告書-第70期第2四半期(2023/07/01-2023/09/30)
Japanese 205.3 KB
2023-08-07 07:04
Report Publication Announcement
確認書
Japanese 8.3 KB

Automate Your Workflow. Get a real-time feed of all ZERIA PHARMCEUTICAL CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for ZERIA PHARMCEUTICAL CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
H. Lundbeck A Logo
Develops and commercializes innovative therapeutics for brain diseases globally.
Denmark HLUN
Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.
South Korea 145020
Human Stem Cells Institute PJSC Logo
A biotech investor developing gene therapy, regenerative medicine, and genetic services.
Russian Federation ISKJ
HUMASIS CO., LTD. Logo
Develops & manufactures rapid in-vitro diagnostic test kits & instruments for global POCT markets.
South Korea 205470
Humedix Co., Ltd. Logo
Develops hyaluronic acid-based pharma, aesthetics, medical devices, and offers CMO services.
South Korea 200670
HUONS CO., LTD. Logo
Global healthcare company providing pharmaceuticals, medical devices, and wellness products.
South Korea 243070
Huons Global Co., Ltd. Logo
Develops pharmaceuticals, medical devices, cosmetics, and health foods for the global market.
South Korea 084110
Hong Kong N/A
HWAIL PHARM. CO., LTD Logo
Develops and manufactures APIs, finished drugs, and functional ingredients for healthcare.
South Korea 061250
Hyloris Pharmaceuticals SA Logo
A biopharma company optimizing existing drugs for unmet needs via abbreviated pathways.
Belgium HYL

Talk to a Data Expert

Have a question? We'll get back to you promptly.